
DiaVision is a digital healthcare solutions company focused on home testing and point-of-care data. They aim to extend healthy life expectancy by collecting biomarker data through their SmartVision technology, enabling easy and accurate testing anytime, anywhere. This data is used to build personalized big data systems for disease prediction and prevention through lifestyle modifications, creating what they call a 'digital vaccine'. Their core technology includes rapid diagnostic kit analytical solutions that allow real-time analysis on-site without expensive equipment. They also offer personalized health management solutions based on biomarker data for areas like hormones, stress, Vitamin D, and diabetes. DiaVision holds 11 core technology patents, including those in AI and biosensors, and claims 98% sensitivity and specificity in clinical trials. They collaborate with various partners, including Samsung Electronics, and have secured supply contracts and MOU agreements.

DiaVision is a digital healthcare solutions company focused on home testing and point-of-care data. They aim to extend healthy life expectancy by collecting biomarker data through their SmartVision technology, enabling easy and accurate testing anytime, anywhere. This data is used to build personalized big data systems for disease prediction and prevention through lifestyle modifications, creating what they call a 'digital vaccine'. Their core technology includes rapid diagnostic kit analytical solutions that allow real-time analysis on-site without expensive equipment. They also offer personalized health management solutions based on biomarker data for areas like hormones, stress, Vitamin D, and diabetes. DiaVision holds 11 core technology patents, including those in AI and biosensors, and claims 98% sensitivity and specificity in clinical trials. They collaborate with various partners, including Samsung Electronics, and have secured supply contracts and MOU agreements.